According to the latest report by IMARC Group, titled, “Infection Surveillance Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global infection surveillance solutions market size reached US$ 580.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,177.7 Million by 2028, exhibiting a growth rate (CAGR) of 12.1% during 2023-2028.
Infection surveillance solutions are protocols utilized to examine preventive measures and recognize infections. They comprise various data, such as the health of employees, surgical information, and real-time medical records of patients, which are extremely valuable for the proper functioning of a healthcare center. They rely on software that can be customized according to the requirements of the healthcare organization for instant identifications, task completion, and comprehensive surveillance. They assist in diagnosing novel bacteria resistant to antibiotics and various infections that spread through the utilization of unsterilized medical equipment. They are effective in preventing the occurrence of various healthcare-associated infections (HAIs), such as ventilator-associated pneumonia (VAP), central line-associated bloodstream infection (CLABSI), catheter-associated urinary tract infections (CAUTI), surgical site infections (SSI), and skin infections. They keep a detailed track of various infections and diseases while helping healthcare providers reduce the spread of those infections and maintain the health of the patients. They aid in providing quality healthcare to individuals and increasing their recovery rates with appropriate disease management methods. As infection surveillance solutions are used to maintain aseptic environments within the premises, improve efficiency in hygiene maintenance, and restrict the spread of infection-causing microbes, they find extensive applications in hospitals and clinics across the globe.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/infection-surveillance-solutions-market/requestsample
Infection Surveillance Solutions Market Trends and Drivers:
The increasing demand for infection surveillance solutions in the healthcare industry to prevent the spread of catheter-associated urinary tract infections (UTIs), central line-associated bloodstream infections, and VAP around the world represents one of the key factors driving the market. Besides this, there is a rise in the number of surgeries due to the increasing occurrence of chronic and life-threatening diseases. This, coupled with the growing geriatric population across the globe, is positively influencing the market. In addition, governments of various countries are taking measures to make the adoption of infection surveillance solutions mandatory in hospitals, clinics, laboratories, and local public health dispensaries to enhance public health. Apart from this, the growing integration of cloud-based bioinformatics solutions for real-time patient monitoring, spontaneous disease recognition, and management of antibiotic-resistant bacteria is offering a favorable market outlook. Additionally, the rising number of hospitals and nursing homes to provide quality healthcare facilities to individuals is strengthening the growth of the market. Moreover, key market players are investing in research and development (R&D) activities to enhance the functionality of infection surveillance solutions with artificial intelligence (AI) and the internet of things (IoT), which is bolstering the growth of the market.
Infection Surveillance Solutions Market 2023-2028 Competitive Analysis and Segmentation:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Baxter International Inc.
- Becton Dickinson and Company
- Centrak Inc. (Halma plc)
- Cerner Corporation
- CKM Healthcare Incorporated
- Ecolab Inc.
- International Business Machines Corporation
- Medexter Healthcare
- Perahealth Inc.
- Premier Inc.
- Sunquest Information Systems Inc. (Roper Technologies Inc.).
The report has segmented the market based on component, deployment type and end user.
Breakup by Component:
Breakup by Deployment Type:
Breakup by End User:
- Ambulatory Service Centers
- Specialty Centers
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/infection-surveillance-solutions-market
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal